Advertisement
Screener

Telomir Pharmaceuticals, Inc. (TELO) ROA

Telomir Pharmaceuticals, Inc. (TELO) ROA

  • 2026-06-30: ROA -109.51%.
  • 2026-03-31: ROA -159.33%.
  • 2025-12-31: ROA -141.84%.
  • 2025-09-30: ROA -151.99%.

Complete source-backed roa history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-109.51%
2026-03-31-159.33%
2025-12-31-141.84%
2025-09-30-151.99%
2025-06-30-1945.35%
2025-03-31-2536.29%
2024-12-31-1248.69%
2024-09-30-2203.64%
2024-06-30-888.90%
2024-03-31-537.91%
2023-12-31-273.83%

Annual ROA

DateROA
2025-12-31-141.84%
2024-12-31-1248.69%
2023-12-31-273.83%
2022-12-31-1752.82%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Rallybio Corp (RLYB)United States$0.089B
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94